Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies

Facilitated subcutaneous immunoglobulin (fSCIG) replacement therapy is the latest method of IgG administration; however, real-life data are limited. We retrospectively analyzed the everyday experience of fSCIG administration, particularly, the method used to switch from intravenous immunoglobulin (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesik-Szewczyk, Ewa, Sołdacki, Dariusz, Paczek, Leszek, Jahnz-Różyk, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326142/
https://www.ncbi.nlm.nih.gov/pubmed/32670265
http://dx.doi.org/10.3389/fimmu.2020.00981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326142/
https://www.ncbi.nlm.nih.gov/pubmed/32670265
http://dx.doi.org/10.3389/fimmu.2020.00981

Ejemplares similares